InvestorsHub Logo
Followers 155
Posts 2666
Boards Moderated 0
Alias Born 01/29/2004

Re: RedShoulder post# 466955

Thursday, 08/08/2024 5:21:04 PM

Thursday, August 08, 2024 5:21:04 PM

Post# of 468245
Then, Anavex Captures the Global Schizophrenia Market

I was being conservative for the first few quarters of revenues reported as the drug is rolled out, notifications released, and pharmaceuticals build the inventory .

Neither of us, in our postings today, accurately told what will be the full Anavex story. Not just blarcamesine for Alzheimer’s. A gigantic market need that Anavex will fulfill.

But what if Anavex’s schizophrenia trial turns up positive — as I believe it will?

Giant global market for a safe, inexpensive drug that is proven to successfully treat schizophrenia symptoms. Once the Anavex drug is discovered to treat schizo, as with blarcamesine against Alzheimer’s, there will be overwhelming economic forces to make the Anavex drug the SOC (standard of care), preferred drug for this severe disease.

With both of these diseases being treated globally by Anavex, widen the columns on the spreadsheets used to calculate eventual Anavex revenues.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News